United States Department of Veterans Affairs
JRRD HomePage

Volume 46 Number 9, 2009
   Pages 1121 — 1126

Abstract – Reference equation for 6-minute walk in individuals with Parkinson disease

Michael J. Falvo, MS;1 Gammon M. Earhart, PT, PhD1-2*

1Program in Physical Therapy and 2Department of Anatomy and Neurobiology and Department of Neurology, Washington University School of Medicine, St. Louis, MO

Abstract — Normal values, as well as determining factors, for the 6-minute walk test are available for nondisabled adults, but less is known about individuals with Parkinson disease (PD). This study created a PD-specific reference equation and identified unique factors associated with 6-minute walk distance (6MWD). Eighty individuals (mean +/- standard deviation [SD] age: 66.3 +/- 9.8 yr) with mild to moderate PD underwent a neurological examination and completed a small battery of tests to assess their balance confidence, fall risk, mobility, and balance. Their mean +/- SD 6MWD was 394.1 +/- 98.4 m (95% confidence interval: 370.0-418.1). Stepwise multiple regression analysis demonstrated that timed up-and-go (TUG) test, one-leg stance (OLS) test, and sex were significant independent contributors to 6MWD and accounted for 56.6% of the variance. The resulting PD-specific regression equation is 6MWDpred = 543.06 + (-10.83 × TUG) + (2.04 × OLS) + (-44.44 × sex). (For sex, 0 = female, 1 = male.) Future interpretation of 6MWD in individuals with PD may be enhanced if expressed as a percentage of the value predicted utilizing this reference equation.

Key words: 6-minute walk distance, exercise test, Freezing of Gait questionnaire, functional capacity, one-leg stance test, Parkinson disease, reference equation, timed up-and-go test, UPDRS, walking.


View HTML   ¦    View PDF   ¦    Contents Vol. 46, No. 9

Current Issue 49-3

At a Glance

Browse JRRD

By Year
By Topic
By Volume

Spotlight

See the PowerPoint Presentation. See the PowerPoint Presentation.
Read the Article Read the Most Downloaded.
Listen to the PodCast. Listen to the PodCast.

Follow Us